
Chinese cell therapy company with operations in Suzhou, Jiangsu and Shanghai, developing allogeneic cell therapies derived from induced pluripotent stem cells. Builds clinical grade iPSC lines and differentiated cell products for neurological conditions including Parkinson's disease and amyotrophic lateral sclerosis and for other degenerative indications, running its own GMP manufacturing and process development for off the shelf cell products.
評価を残す